Is DYN undervalued or overvalued?
As of 2025-03-21, the Intrinsic Value of Dyne Therapeutics Inc (DYN) is -14.03 USD. This DYN valuation is based on the model Peter Lynch Fair Value. With the current market price of 12.40 USD, the upside of Dyne Therapeutics Inc is -213.15%. This means that DYN is overvalued by 213.15%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -14.03 - -14.03 | -14.03 | -213.15% |
P/E | (12.91) - (43.77) | (29.11) | -334.8% |
DDM - Stable | (20.71) - (79.74) | (50.22) | -505.0% |
DDM - Multi | (0.31) - (0.93) | (0.47) | -103.8% |
Market Cap (mil) | 1,402.69 |
Beta | 2.04 |
Outstanding shares (mil) | 113.12 |
Enterprise Value (mil) | 967.24 |
Market risk premium | 4.60% |
Cost of Equity | 10.33% |
Cost of Debt | 5.00% |
WACC | 7.00% |